Catalyst Wire Dossier Catalyst Wire Dossier

NCX-1000

NCX-1000 · Forest Laboratories
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NCX-1000, covering 2017-02-09 to 2017-02-09. Get the full timeline:

Most recent: Clinical Trial Update: Preliminary Efficacy and Tolerability of NCX-1000 After Repeated Oral Doses in Patients With Elevated Portal Pressure [Phase 2]

See pricing